Laserscope Announces Strategic Alliance with Walt Disney Co
Laserscope Announces Strategic Alliance with Celebration Health;
State-of-the-Art Hospital is Centerpiece of New Walt Disney-Inspired
Community
ORLANDO, FLA. (Nov. 20) BW HEALTHWIRE -Nov. 20, 1997--Laserscope
(NASDAQ:LSCP) announced today that it has entered into a strategic
alliance with Celebration Health, a new, innovative health care
facility in the Walt Disney-inspired community of Celebration, Fla.
near Orlando.
The Celebration Company, a wholly owned subsidiary of The Walt Disney
Company, selected Florida Hospital to lead the development of Celebration Health, the community's health cornerstone. The new 315,
000-sq. ft. facility features state-of-the-art surgery and diagnostic
centers, rehabilitation and sports medicine clinics, health activities
and fitness centers, primary care services, specialty physicians, a
dental clinic and a pharmacy. Its phase one grand opening is taking
place this week.
"We are pleased to join forces with a medical facility like Celebration Health," said Robert V. McCormick, President and CEO of Laserscope. "Leading physicians and hospital administrators from around the world will visit the facility to examine advanced medical technology and the very latest in patient care. Celebration Health will be a national showcase for Laserscope's innovative medical products." "At Laserscope, we believe advanced technology leads to improved patient care. Celebration Health's mission and philosophy are very much in concert with our own patient care vision by providing the very best in optimized treatments and therapies. Both organizations are fully committed to improving the quality and cost effectiveness of the health care delivery system," McCormick said.
"Laserscope was asked to be one of Celebration Health's corporate
partners because of its reputation as a market leader in medical and
surgical laser technology. Its products have a reputation for value
and innovation," said Des Cummings, CEO of Celebration Health.
Among Celebration Health's other strategic partners are Johnson &
Johnson, General Electric Medical Systems, GlaxoWellcome, Sprint,
Wyeth-Ayerst Laboratories, Delta Dental and Astra Merck.
At Celebration, Laserscope has supplied products from its Ascent
Medical Systems(TM) (AMS) line. The products represent the latest in
surgical suite design and include: ceiling mounted equipment
organizers, which move operating room equipment and patient monitoring
devices off the floor to optimal positions overhead to improve OR
turnover time, as well as CVAC(R) centralized smoke evacuation systems
to remove harmful microscopic debris from the air to protect patients
and health care workers.
An important feature of the Celebration surgical suite will be
Laserscope's Hanauvision(TM) Interactive Surgical Video System which
allows viewing of live or recorded procedures and provides uplinks for
remote diagnostics and teaching purposes. Celebration Health's
surgical video network is the latest in telemedicine allowing for
easier consulting, treating, teaching, teleconferencing and documentation of cases.
Celebration Health also selected Laserscope's new Pulsar(TM) Laser
System for the new facility. The Pulsar is an effective skin
resurfacing (wrinkle removal) laser as well as a versatile surgical
laser with applications in gynecology and ear, nose and throat surgery. "Celebration Health's goal is to create a healthy community model and a healthy company model allowing each citizen to realize optimum health as a foundation for the pursuit of happiness. The medical center will serve Central Florida as well as a national and international visitors.
We are pleased to have Laserscope as one of our partners in this new
and exciting venture," said Cummings.Laserscope designs, manufactures, sells and services on a worldwide basis an advanced line of medical laser systems and related energy delivery devices for the office, outpatient surgical center and hospital markets. The Company is a pioneer in the development and commercialization of lasers and devices for photoselective medicine to treat cancer and other diseases. It has a strategic alliance with QLT PhotoTherapeutics, Inc., whose proprietary drug PHOTOFRIN(R), which can be activated by Laserscope light sources, is the only photodynamic therapy drug to date to receive marketing clearance in any world jurisdiction. Its Ascent Medical Systems(TM) (AMS) provide innovative,custom equipment solutions for surgical suites and medical treatment rooms. More information on Laserscope and its products can be found on the Company's Website at www.laserscope.com .
Statements in this announcement about future results are preliminary
and based on partial information and assumptions. Except for the
historical information presented, the matters discussed in this
announcement contain forward-looking statements that involve risks and
uncertainties, including the timely introduction and market acceptance
of new products and procedures, the development and rate of growth of
new markets and treatments, the impact of competitive products and
technologies, consumer acceptance of and demand for the medical
procedures targeted by the company, and other risks detailed from time
to time in the Company's public disclosure filings with the U.S.
Securities and Exchange Commission (SEC). Copies of the most recent
Forms 10K and 10Q are available upon request from Laserscope's Investor
Relations Department.
-0- eb/sf*
CONTACT: Laserscope
Richard Wood, 408/943-0636 (IR/Media)
Dennis LaLumandiere, 408/943-0636 (Financial)
or
Hilary Kaye Associates
Hilary Kaye or Shelle Murach, 714/851-5150
KEYWORD: FLORIDA
INDUSTRY KEYWORD: MEDICINE Today's News On The Net - Business Wire's
full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
End of Report |
